ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for INSM

Stock NameInsmed Inc
TickerINSM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4576693075
LEI529900Q55QAG41CCAC11

Show aggregate INSM holdings

News associated with INSM

Analysts Set Insmed, Inc. (NASDAQ:INSM) Price Target at $139.86
Insmed, Inc. (NASDAQ:INSM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year target price among brokerages […] - 2025-09-17 02:58:45
Insmed (NASDAQ:INSM) Reaches New 12-Month High on Analyst Upgrade
Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) hit a new 52-week high on Monday after Guggenheim raised their price target on the stock from $125.00 to $172.00. Guggenheim currently has a buy rating on the stock. Insmed traded as high as $146.91 and last traded at $145.86, with a volume of 288114 shares […] - 2025-09-10 02:26:50
Top Analyst Reports for Microsoft, Amazon.com & Philip Morris
Microsoft, Amazon.com and Philip Morris headline fresh analyst reports highlighting AI, cloud, and smoke-free growth momentum. - 2025-09-05 18:11:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Insmed (NASDAQ:INSM) Earns Outperform Rating from Analysts at William Blair
Stock analysts at William Blair initiated coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The firm set an “outperform” rating on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the stock. Truist Financial upped their target price on shares […] - 2025-08-22 02:54:45
IMCB's Underlying Holdings Could Mean 12% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-18 09:44:41
The Goldman Sachs Group Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) Stock
Insmed (NASDAQ:INSM – Get Free Report) had its target price increased by equities researchers at The Goldman Sachs Group from $114.00 to $142.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential upside […] - 2025-08-15 07:10:57
INSM Crosses Above Average Analyst Target
In recent trading, shares of Insmed Inc (Symbol: INSM) have crossed above the average analyst 12-month target price of $119.12, changing hands for $122.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-08-13 10:41:52
Insmed (NASDAQ:INSM) Reaches New 1-Year High Following Analyst Upgrade
Insmed, Inc. (NASDAQ:INSM – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Wells Fargo & Company raised their price target on the stock from $119.00 to $130.00. Wells Fargo & Company currently has an overweight rating on the stock. Insmed traded as high as $113.41 and last […] - 2025-08-13 02:23:00
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Insmed, Inc. (NASDAQ:INSM) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 3.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 1,602,655 shares of the biopharmaceutical company’s stock after buying an additional 56,048 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Insmed were […] - 2025-08-12 05:59:02
Mackenzie Financial Corp Acquires 2,220 Shares of Insmed, Inc. (NASDAQ:INSM)
Mackenzie Financial Corp lifted its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 20.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,103 shares of the biopharmaceutical company’s stock after buying an additional 2,220 shares during the quarter. Mackenzie Financial Corp’s holdings in […] - 2025-08-06 05:07:44
Insmed, Inc. (NASDAQ:INSM) Shares Acquired by Cwm LLC
Cwm LLC grew its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 24.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,052 shares of the biopharmaceutical company’s stock after buying an additional 404 shares during the quarter. Cwm LLC’s holdings in Insmed were worth $157,000 as of its most recent SEC filing. Several […] - 2025-07-29 04:28:55
Allianz Asset Management GmbH Has $5.74 Million Holdings in Insmed, Inc. (NASDAQ:INSM)
Allianz Asset Management GmbH raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 4.9% in the first quarter, Holdings Channel.com reports. The firm owned 75,284 shares of the biopharmaceutical company’s stock after buying an additional 3,534 shares during the period. Allianz Asset Management GmbH’s holdings in Insmed were worth $5,743,000 as […] - 2025-07-28 05:46:50
Congress Trade: Representative Josh Gottheimer Just Disclosed New Stock Trades
Representative Josh Gottheimer just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Josh Gottheimer and other politicians. - 2025-07-17 10:12:46
Insmed, Inc. (NASDAQ:INSM) Shares Bought by Xponance Inc.
Xponance Inc. boosted its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,359 shares of the biopharmaceutical company’s stock after buying an additional 670 shares during the period. Xponance Inc.’s holdings in Insmed […] - 2025-07-17 06:35:03
Envestnet Asset Management Inc. Grows Holdings in Insmed, Inc. (NASDAQ:INSM)
Envestnet Asset Management Inc. raised its position in Insmed, Inc. (NASDAQ:INSM – Free Report) by 26.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 325,307 shares of the biopharmaceutical company’s stock after purchasing an additional 68,949 shares during the quarter. Envestnet Asset Management […] - 2025-07-16 07:23:19
Sara Bonstein Sells 57,764 Shares of Insmed, Inc. (NASDAQ:INSM) Stock
Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,764 shares of the company’s stock in a transaction on Monday, July 7th. The shares were sold at an average price of $95.86, for a total value of $5,537,257.04. Following the completion of the sale, the chief financial officer owned 84,017 shares in the […] - 2025-07-11 05:13:00
Teacher Retirement System of Texas Sells 2,654 Shares of Insmed, Inc. (NASDAQ:INSM)
Teacher Retirement System of Texas lessened its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 45,683 shares of the biopharmaceutical company’s stock after selling 2,654 shares during the period. Teacher Retirement System of Texas’ holdings in Insmed were worth $3,485,000 at […] - 2025-07-09 05:48:57
Brokerages Set Insmed, Inc. (NASDAQ:INSM) Target Price at $106.80
Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) have earned an average rating of “Buy” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. Seventeen equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the […] - 2025-07-04 02:40:47
Insmed, Inc. (NASDAQ:INSM) CFO Sara Bonstein Sells 57,765 Shares
Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,765 shares of the stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $101.78, for a total value of $5,879,321.70. Following the completion of the sale, the chief financial officer now owns 93,536 shares in the […] - 2025-06-27 05:06:55
Avior Wealth Management LLC Raises Holdings in Insmed, Inc. (NASDAQ:INSM)
Avior Wealth Management LLC lifted its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 82.2% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 4,151 shares of the biopharmaceutical company’s stock after acquiring an additional 1,873 shares during the period. Avior Wealth Management LLC’s holdings […] - 2025-06-23 05:12:58
Is Insmed Stock Overvalued at $98?
Insmed Inc (NASDAQ: INSM) was nothing short of a juggernaut last month, skyrocketing 45%, while the S&P500 index gained 3% during the same period. What’s fueling the fire? Insmed announced that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonar - 2025-06-17 03:35:22
Notable ETF Outflow Detected - IWO, SFM, INSM, FTAI
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Growth ETF (Symbol: IWO) where we have detected an approximate $123.7 million dollar outflow -- that's a 1.1% decrease week ove - 2025-06-16 11:49:52
Insmed Incorporated (NASDAQ:INSM) CFO Sells $5,148,105.92 in Stock
Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,766 shares of the company’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $89.12, for a total transaction of $5,148,105.92. Following the sale, the chief financial officer now directly owns 103,412 shares in the company, […] - 2025-06-16 05:18:57
Park Avenue Securities LLC Has $842,000 Holdings in Insmed Incorporated (NASDAQ:INSM)
Park Avenue Securities LLC boosted its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 38.7% during the 1st quarter, Holdings Channel reports. The institutional investor owned 11,036 shares of the biopharmaceutical company’s stock after purchasing an additional 3,081 shares during the quarter. Park Avenue Securities LLC’s holdings in Insmed were worth $842,000 […] - 2025-06-13 05:18:50
Morgan Stanley Increases Insmed (NASDAQ:INSM) Price Target to $102.00
Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by stock analysts at Morgan Stanley from $90.00 to $102.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price suggests a potential upside of 5.28% from the stock’s previous close. […] - 2025-06-13 04:40:52
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
Insmed (NASDAQ:INSM – Get Free Report) had its target price raised by research analysts at Royal Bank of Canada from $99.00 to $106.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 9.41% […] - 2025-06-13 04:40:51
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Mizuho Analyst Says
Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by equities research analysts at Mizuho from $96.00 to $110.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target points to a potential upside of 13.54% from the company’s current price. […] - 2025-06-13 04:40:49
Insmed (NASDAQ:INSM) Shares Up 4.5% Following Analyst Upgrade
Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price traded up 4.5% during trading on Wednesday after The Goldman Sachs Group raised their price target on the stock from $100.00 to $112.00. The Goldman Sachs Group currently has a buy rating on the stock. Insmed traded as high as $93.82 and last traded at $95.02. […] - 2025-06-13 02:17:01

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc INSM holdings

DateNumber of INSM Shares HeldBase Market Value of INSM SharesLocal Market Value of INSM SharesChange in INSM Shares HeldChange in INSM Base ValueCurrent Price per INSM Share HeldPrevious Price per INSM Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INSM by Blackrock for IE00B3VWM098

Show aggregate share trades of INSM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-17SELL-2,596197.880191.825 192.430USD -499,550 97.50 Loss of -246,449 on sale
2025-11-12SELL-236196.330191.940 192.379USD -45,401 96.30 Loss of -22,674 on sale
2025-11-06BUY456188.440183.810 184.273USD 84,028 94.71
2025-11-05SELL-2,340189.305182.090 182.811USD -427,779 94.32 Loss of -207,071 on sale
2025-11-04SELL-468187.880182.580 183.110USD -85,695 93.94 Loss of -41,731 on sale
2025-11-03SELL-464188.555178.760 179.739USD -83,399 93.55 Loss of -39,994 on sale
2025-10-28BUY699165.290167.070 166.892USD 116,658 92.05
2025-10-24SELL-231159.660162.290 162.027USD -37,428 91.44 Loss of -16,306 on sale
2025-10-15BUY1,386163.540165.760 165.538USD 229,436 89.14
2025-10-07BUY231162.320162.440 162.428USD 37,521 88.11
2025-10-02BUY232152.800152.850 152.845USD 35,460 87.16
2025-09-30BUY466144.010145.410 145.270USD 67,696 86.60
2025-09-24BUY462141.000145.560 145.104USD 67,038 85.60
2025-09-16BUY468144.750144.840 144.831USD 67,781 85.03
2025-09-11BUY932145.790147.100 146.969USD 136,975 84.43
2025-09-04BUY696142.530145.000 144.753USD 100,748 83.53
2025-08-29BUY936136.100136.100 136.100USD 127,390 82.69
2025-08-27BUY468134.530134.740 134.719USD 63,048 82.15
2025-08-26BUY2,231132.170132.310 132.296USD 295,152 81.90
2025-08-21SELL-227132.600132.640 132.636USD -30,108 81.13 Loss of -11,692 on sale
2025-08-15BUY2,270127.800128.000 127.980USD 290,515 80.38
2025-08-06SELL-454111.260112.290 112.187USD -50,933 79.50 Loss of -14,841 on sale
2025-08-04SELL-454111.240111.280 111.276USD -50,519 79.15 Loss of -14,586 on sale
2025-07-31BUY681107.280108.640 108.504USD 73,891 78.83
2025-07-28SELL-227101.750105.800 105.395USD -23,925 78.40 Loss of -6,128 on sale
2025-07-25SELL-227103.950105.080 104.967USD -23,828 78.26 Loss of -6,064 on sale
2025-07-17BUY893104.170105.350 105.232USD 93,972 77.37
2025-06-30SELL-448100.640101.640 101.540USD -45,490 75.59 Loss of -11,625 on sale
2025-06-25SELL-224104.850106.830 106.632USD -23,886 75.08 Loss of -7,069 on sale
2025-06-20SELL-448102.680102.810 102.797USD -46,053 74.49 Loss of -12,683 on sale
2025-05-23BUY22467.53067.650 67.638USD 15,151 73.42
2025-05-19SELL-22467.88068.990 68.879USD -15,429 73.62 Profit of 1,062 on sale
2025-05-15SELL-67267.22067.220 67.220USD -45,172 73.72 Profit of 4,366 on sale
2025-05-12SELL-22467.75068.510 68.434USD -15,329 73.90 Profit of 1,224 on sale
2025-05-09SELL-22465.08066.910 66.727USD -14,947 73.97 Profit of 1,623 on sale
2025-04-30BUY1,01772.00072.370 72.333USD 73,563 74.20
2025-04-24SELL-44068.96071.000 70.796USD -31,150 74.36 Profit of 1,567 on sale
2025-04-17SELL-22072.65072.670 72.668USD -15,987 74.50 Profit of 403 on sale
2025-04-15SELL-66071.07071.980 71.889USD -47,447 74.57 Profit of 1,772 on sale
2025-04-14SELL-66071.03071.240 71.219USD -47,005 74.61 Profit of 2,237 on sale
2025-04-09SELL-88467.55068.700 68.585USD -60,629 74.84 Profit of 5,529 on sale
2025-04-07SELL-1,54768.09070.520 70.277USD -108,719 75.01 Profit of 7,324 on sale
2025-04-04SELL-2,21069.18072.500 72.168USD -159,491 75.07 Profit of 6,417 on sale
2025-03-31BUY22176.29076.700 76.659USD 16,942 75.11
2025-03-19SELL-44278.94078.980 78.976USD -34,907 74.79 Loss of -1,849 on sale
2025-03-14SELL-1,32676.55077.410 77.324USD -102,532 74.71 Loss of -3,469 on sale
2025-03-13SELL-44475.07075.560 75.511USD -33,527 74.70 Loss of -359 on sale
2025-03-12SELL-7,54874.04076.310 76.083USD -574,274 74.71 Loss of -10,350 on sale
2025-03-07SELL-44474.89076.170 76.042USD -33,763 74.74 Loss of -576 on sale
2025-03-06SELL-66675.02077.830 77.549USD -51,648 74.74 Loss of -1,871 on sale
2025-03-04BUY1,47577.21078.410 78.290USD 115,478 74.67
2025-03-03SELL-21876.29081.550 81.024USD -17,663 74.65 Loss of -1,390 on sale
2025-02-28SELL-1,30881.55081.620 81.613USD -106,750 74.55 Loss of -9,237 on sale
2025-02-26SELL-21878.10079.880 79.702USD -17,375 74.44 Loss of -1,148 on sale
2025-02-25SELL-65477.50081.670 81.253USD -53,139 74.39 Loss of -4,487 on sale
2025-02-18BUY1,09081.36082.040 81.972USD 89,349 73.80
2025-02-13BUY21878.67079.690 79.588USD 17,350 73.54
2025-02-12BUY21879.60080.280 80.212USD 17,486 73.44
2025-02-11BUY65479.89080.010 79.998USD 52,319 73.33
2025-02-06BUY1,96280.78082.040 81.914USD 160,715 72.99
2025-01-27BUY21877.63078.690 78.584USD 17,131 72.09
2025-01-22SELL-43678.45078.550 78.540USD -34,243 71.68 Loss of -2,993 on sale
2025-01-17SELL-21872.51073.630 73.518USD -16,027 71.52 Loss of -437 on sale
2025-01-16BUY21872.75073.220 73.173USD 15,952 71.49
2025-01-14BUY65468.29070.220 70.027USD 45,798 71.60
2025-01-13BUY43668.93069.410 69.362USD 30,242 71.67
2025-01-08BUY1,30865.72066.500 66.422USD 86,880 72.19
2024-12-30BUY1,08868.87069.600 69.527USD 75,645 72.36
2024-12-06BUY86875.40076.980 76.822USD 66,681 72.24
2024-12-05BUY21775.33078.830 78.480USD 17,030 72.13
2024-12-04BUY1,08575.36075.560 75.540USD 81,961 72.02
2024-11-29BUY1,08575.16076.530 76.393USD 82,886 71.86
2024-11-27BUY86875.88076.650 76.573USD 66,465 71.51
2024-11-26BUY21775.68076.000 75.968USD 16,485 71.32
2024-11-25BUY5,74374.09076.460 76.223USD 437,749 71.19
2024-11-21BUY99573.81074.090 74.062USD 73,692 70.95
2024-11-20BUY59772.67073.950 73.822USD 44,072 70.85
2024-11-18BUY2,38866.61067.260 67.195USD 160,462 70.94
2024-11-12BUY1,59270.14071.860 71.688USD 114,127 70.99
2024-11-08BUY99573.54073.640 73.630USD 73,262 70.81
2024-11-07BUY2,97071.69073.490 73.310USD 217,731 70.74
2024-11-06BUY39672.86074.000 73.886USD 29,259 70.56
2024-10-31BUY19867.28070.390 70.079USD 13,876 71.72
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INSM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19172,5311,415480,68735.9%
2025-09-18192,4191,396488,53239.4%
2025-09-17258,254358657,58639.3%
2025-09-16234,877118631,37937.2%
2025-09-15281,7980849,08733.2%
2025-09-12276,8760792,54934.9%
2025-09-11232,7891,547706,71332.9%
2025-09-10298,194739767,29038.9%
2025-09-09285,0061607,09046.9%
2025-09-08226,229224654,28834.6%
2025-09-05325,826281,044,43831.2%
2025-09-04248,903665733,06334.0%
2025-09-03350,85401,100,91931.9%
2025-09-02978,5203,5282,123,85846.1%
2025-08-29391,48115838,63746.7%
2025-08-28307,99419,763681,03345.2%
2025-08-27359,4230988,38136.4%
2025-08-26309,0849862,40435.8%
2025-08-25328,52686915,12535.9%
2025-08-22499,36801,021,14648.9%
2025-08-21473,4691,317988,73147.9%
2025-08-20436,0533,929931,88346.8%
2025-08-19428,16601,016,55742.1%
2025-08-18562,7181,2681,332,87742.2%
2025-08-15736,274301,803,55640.8%
2025-08-141,023,9343202,229,62245.9%
2025-08-13722,47512,238,83432.3%
2025-08-121,753,6667013,484,21050.3%
2025-08-11511,65101,434,17635.7%
2025-08-08360,30601,213,66529.7%
2025-08-07435,1451861,629,36326.7%
2025-08-06541,4971,8141,567,24534.6%
2025-08-05557,3753,0531,406,78939.6%
2025-08-04510,869481,127,74445.3%
2025-08-01385,7081,1351,044,89536.9%
2025-07-31570,5882,5981,011,30656.4%
2025-07-30777,2961,4001,553,45750.0%
2025-07-29245,874242687,94135.7%
2025-07-28330,814146938,03835.3%
2025-07-25243,537471722,55733.7%
2025-07-24171,39818713,65624.0%
2025-07-23236,916636800,81829.6%
2025-07-22228,3820552,06741.4%
2025-07-21252,5300764,28933.0%
2025-07-18244,4971,210505,60848.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy